详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

The roles of reactive oxygen species (ROS) and autophagy in the survival and death of leukemia cells.

文献详情

资源类型：

作者：

机构： [a]Department of Basic Medical Sciences, School of Medicine of Taizhou University, Taizhou 318000, Zhejiang, China [b]Institute of Tumor, School of Medicine of Taizhou University, Taizhou 318000, Zhejiang, China [c]School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China [d]Biochemistry Department of Purdue University, West Lafayette, IN 47906, USA [e]Department of Histology and Embryology, North SiChuan Medical College, Nanchong 637000, Sichuan, China [f]Department of Hematology, the Affiliated Hospital of Guiyang Medical College, Guiyang 550004, China

出处：

DOI：

ISSN：

摘要：

As a clonal disease of hematopoietic stem cells (HSCs), the etiology and pathogenesis of leukemia is not fully understood. Recent studies suggest that cellular homeostasis plays an essential role in maintaining the function of HSCs because dysregulation of cellular homeostasis is one of the major factors underlying the malignant transformation of HSCs. Reactive oxygen species (ROS) and autophagy, key factors regulating cellular homeostasis, are commonly observed in the human body. Autophagy can be induced by ROS through a variety of signaling pathways, and conversely inhibits ROS-induced damage to cells and tissues. ROS and autophagy coordinate to maintain cellular homeostasis. Previous studies have demonstrated that both of ROS and autophagy play important roles in the development of leukemia and are closely involved in drug resistance in leukemia. Interference with cellular homeostasis by promoting programmed leukemia cell death via ROS and autophagy has been verified to be an efficient technique in the treatment of leukemia. However, the critical roles of ROS and autophagy in the development of leukemia are largely unknown. In this review, we summarize the roles of ROS and autophagy in the pathogenesis of leukemia, which may allow the identification of novel targets and drugs for the treatment of leukemia based on the regulation of HSCs homeostasis through ROS and autophagy. Copyright © 2017 Elsevier B.V. All rights reserved.

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2017]版中科院分区表Review为是的期刊

：

大类 | 2 区医学

小类 | 2 区血液学 2 区肿瘤学

最新[2023]版

：

大类 | 2 区

医学

小类 | 2 区血液学 2 区肿瘤学

第一作者：

第一作者机构： [a]Department of Basic Medical Sciences, School of Medicine of Taizhou University, Taizhou 318000, Zhejiang, China [b]Institute of Tumor, School of Medicine of Taizhou University, Taizhou 318000, Zhejiang, China [*1]School of Medicine of Taizhou University, Taizhou,318000, Zhejiang, China.

通讯作者：

通讯机构： [a]Department of Basic Medical Sciences, School of Medicine of Taizhou University, Taizhou 318000, Zhejiang, China [b]Institute of Tumor, School of Medicine of Taizhou University, Taizhou 318000, Zhejiang, China [*1]School of Medicine of Taizhou University, Taizhou,318000, Zhejiang, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：